These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
737 related articles for article (PubMed ID: 21732606)
1. Theranostic nanoparticles engineered for clinic and pharmaceutics. Ma X; Zhao Y; Liang XJ Acc Chem Res; 2011 Oct; 44(10):1114-22. PubMed ID: 21732606 [TBL] [Abstract][Full Text] [Related]
2. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine. Al-Jamal WT; Kostarelos K Acc Chem Res; 2011 Oct; 44(10):1094-104. PubMed ID: 21812415 [TBL] [Abstract][Full Text] [Related]
8. Polymeric vesicles: from drug carriers to nanoreactors and artificial organelles. Tanner P; Baumann P; Enea R; Onaca O; Palivan C; Meier W Acc Chem Res; 2011 Oct; 44(10):1039-49. PubMed ID: 21608994 [TBL] [Abstract][Full Text] [Related]
9. Nanotheranostics and image-guided drug delivery: current concepts and future directions. Lammers T; Kiessling F; Hennink WE; Storm G Mol Pharm; 2010 Dec; 7(6):1899-912. PubMed ID: 20822168 [TBL] [Abstract][Full Text] [Related]
10. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 2: Imaging, diagnostic, and therapeutic applications. Son SJ; Bai X; Lee SB Drug Discov Today; 2007 Aug; 12(15-16):657-63. PubMed ID: 17706548 [TBL] [Abstract][Full Text] [Related]
11. Engineering nanocomposite materials for cancer therapy. Minelli C; Lowe SB; Stevens MM Small; 2010 Nov; 6(21):2336-57. PubMed ID: 20878632 [TBL] [Abstract][Full Text] [Related]
12. Image guided therapy: the advent of theranostic agents. Terreno E; Uggeri F; Aime S J Control Release; 2012 Jul; 161(2):328-37. PubMed ID: 22626940 [TBL] [Abstract][Full Text] [Related]
13. Multifunctional nanoparticles for multimodal imaging and theragnosis. Lee DE; Koo H; Sun IC; Ryu JH; Kim K; Kwon IC Chem Soc Rev; 2012 Apr; 41(7):2656-72. PubMed ID: 22189429 [TBL] [Abstract][Full Text] [Related]
14. Towards the use of nanoparticles in cancer therapy and imaging. Pauwels EK; Erba P Drug News Perspect; 2007 May; 20(4):213-20. PubMed ID: 17637933 [TBL] [Abstract][Full Text] [Related]
16. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise. Bharali DJ; Mousa SA Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093 [TBL] [Abstract][Full Text] [Related]
17. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Fadeel B; Garcia-Bennett AE Adv Drug Deliv Rev; 2010 Mar; 62(3):362-74. PubMed ID: 19900497 [TBL] [Abstract][Full Text] [Related]
18. Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern. Lam PL; Wong WY; Bian Z; Chui CH; Gambari R Nanomedicine (Lond); 2017 Feb; 12(4):357-385. PubMed ID: 28078952 [TBL] [Abstract][Full Text] [Related]
19. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance. Shapira A; Livney YD; Broxterman HJ; Assaraf YG Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184 [TBL] [Abstract][Full Text] [Related]
20. Liposome-nanoparticle hybrids for multimodal diagnostic and therapeutic applications. Al-Jamal WT; Kostarelos K Nanomedicine (Lond); 2007 Feb; 2(1):85-98. PubMed ID: 17716195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]